This move is archived. Current quotes and coverage live on the stock page.
Follow AVCN
Avicanna Inc's stock surged 12% in a single trading day, fueled by strategic investments and positive market sentiment.
Avicanna Inc (AVCN.TO) experienced a remarkable 12% increase in its stock price during the last trading session, closing at CA$0.14. This surge is attributed to a significant investment from Splash Beverage Group, which has positioned Avicanna as a frontrunner in the cannabinoid biopharmaceutical space.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.11M
52W high
$0.30
52W low
$0.10
1W change
-4.55%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 566.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+566.7% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
91.8%
Annualized
90-Day Vol
79.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.14 |
| 60 trading days | C$0.09 | C$0.06 – C$0.15 |
| 90 trading days | C$0.09 | C$0.05 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Avicanna's ongoing developments and its strategic positioning in the growing cannabinoid healthcare market, which could lead to further growth opportunities.
Avicanna Inc's stock up 12% in one day
The stock's rise reflects growing investor interest and confidence in Avicanna's strategic direction and market potential.
Bull case
The recent CDN$300,000 investment from Splash Beverage Group showcases Avicanna's potential and credibility in the cannabinoid sector. This backing suggests strong confidence in its business model and future growth prospects.
Bear case
Despite the positive momentum, Avicanna's current profit margin is negative, which indicates ongoing challenges in achieving profitability. This situation could raise concerns among more cautious investors.
Advertisement
Strategic Investment Boosts Confidence
The recent CDN$300,000 investment from Splash Beverage Group has significantly boosted Avicanna's stock performance. This investment not only reflects confidence in Avicanna's business model but also positions the company favorably within the expanding cannabinoid healthcare market. As the U.S. healthcare landscape evolves, Avicanna's established platform and expertise may become increasingly valuable.
Market Reaction and Future Prospects
The market's positive reaction to Avicanna's recent developments indicates a growing interest in cannabinoid-based healthcare solutions. With a solid foundation in clinical research and a diverse product portfolio, Avicanna is well-positioned to capitalize on the increasing demand for cannabinoid therapies. Investors are encouraged to monitor the company's progress as it navigates this dynamic sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
